Energy Transfer Isn’t Done Making Deals
The MLP believes the midstream sector remains ripe for consolidation.
Could ARM Holdings Dethrone Nvidia?
ARM’s customers are starting to make products that are challenging Nvidia’s GPU business.
Affirm: Buy, Sell, or Hold?
This misunderstood fintech is loaded with potential upside.
The Best Artificial Intelligence (AI) ETF to Invest $1,000 in Right Now
They may be in the same category of exchange-traded funds, but not all artificial intelligence ETFs are the same.
This Warren Buffett Stock Is a No-Brainer Buy
How many brands can compare to Coke?
3 Growth Stocks That Could Continue Outperforming the Nasdaq-100
There are growth opportunities across every sector of the market if you know where to look.
Billionaires Are Buying Beaten-Down Pfizer Stock Hand Over Fist. Should You Follow Their Lead?
Pfizer stock lost nearly half its value over the past couple of years, but some of the world’s most successful investors bought millions of shares in the first quarter.
2 Unstoppable Artificial Intelligence (AI) Growth Stocks You Can Buy and Hold for the Next Decade
These rapidly expanding companies could be among the biggest winners of the AI revolution.
2 Artificial Intelligence (AI) Stocks You Can Buy and Hold for the Next Decade
These companies didn’t get a headstart in AI but have massive potential in the market over the long term.
With a 12% Dividend Yield, Is Medical Properties Trust Finally a Buy?
This REIT’s yield might look tempting, but know what you’re getting into.
‘I feel like I’m Alice in Wonderland’: Why nightmares and ‘daymares’ could be early warning signs of autoimmune disease
An increase in nightmares and hallucinations — or ‘daymares’ — could herald the onset of autoimmune diseases such as lupus.